K J Ruddy

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 23:3075-81. 2012
  2. ncbi Quality of life and symptoms in male breast cancer survivors
    Kathryn J Ruddy
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast 22:197-9. 2013
  3. ncbi Patient adherence and persistence with oral anticancer treatment
    Kathryn Ruddy
    Department of Breast Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA
    CA Cancer J Clin 59:56-66. 2009
  4. ncbi Genetic testing in young women with breast cancer: results from a Web-based survey
    K J Ruddy
    Department of Adult Oncology, Breast Oncology Center, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Ann Oncol 21:741-7. 2010
  5. ncbi Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Menopause 18:105-8. 2011

Detail Information

Publications5

  1. ncbi Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
    K J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    Ann Oncol 23:3075-81. 2012
    ..We sought to measure persistence with CMF, adherence to oral cyclophosphamide, and the association of these with toxic effects...
  2. ncbi Quality of life and symptoms in male breast cancer survivors
    Kathryn J Ruddy
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast 22:197-9. 2013
    ..Little is known about quality of life and symptoms of male breast cancer survivors...
  3. ncbi Patient adherence and persistence with oral anticancer treatment
    Kathryn Ruddy
    Department of Breast Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA 02115, USA
    CA Cancer J Clin 59:56-66. 2009
    ..Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described...
  4. ncbi Genetic testing in young women with breast cancer: results from a Web-based survey
    K J Ruddy
    Department of Adult Oncology, Breast Oncology Center, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Ann Oncol 21:741-7. 2010
    ..Young women with breast cancer have an increased risk for harboring a BRCA1 or BRCA2 mutation. Frequency of genetic testing and factors associated with testing have not been well described in this population...
  5. ncbi Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls
    Kathryn J Ruddy
    Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Menopause 18:105-8. 2011
    ..However, there has been little research to date comparing young survivors’ concerns and symptoms with those of young women of the same age and gravidity in the general population...